Thomas Jefferson University

Ashwin Sama

TitleAsst Professor
InstitutionThomas Jefferson University
DepartmentMedical Oncology
Address1025 Walnut St.
Philadelphia PA 19107
Phone215-955-8874
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Jacobs SA, Lee JJ, George TJ, Wade JL, Stella PJ, Wang D, Sama A, Piette F, Pogue-Geile KL, Kim RS, Gavin PG, Lipchik C, Feng H, Wang Y, Finnigan M, Kiesel B, Beumer JH, Wolmark N, Lucas PC, Allegra CJ, Srinivasan A. Neratinib plus Cetuximab in Quadruple WT (KRAS, NRAS, BRAF, PIK3CA) Metastatic Colorectal Cancer Resistant to Cetuximab or Panitumumab: NSABP FC-7, A Phase Ib Study. Clin Cancer Res. 2020 Nov 17. PMID: 33203645.
      Citations:    
    2. He AR, Cohen RB, Denlinger CS, Sama A, Birnbaum A, Hwang J, Sato T, Lewis N, Mynderse M, Niland M, Giles J, Wallin J, Moser B, Zhang W, Walgren R, Plimack ER. First-in-Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced Cancer. Oncologist. 2019 Mar 04. PMID: 30833489.
      Citations:    
    3. Hurwitz H, Van Cutsem E, Bendell J, Hidalgo M, Li CP, Salvo MG, Macarulla T, Sahai V, Sama A, Greeno E, Yu KH, Verslype C, Dawkins F, Walker C, Clark J, O'Reilly EM. Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies. Invest New Drugs. 2018 08; 36(4):683-695. PMID: 29508247.
      Citations:    
    4. O'Hayer CVF, O'Hayer KM, Sama A. Acceptance and Commitment Therapy with Pancreatic Cancer: An Integrative Model of Palliative Care-A Case Report. J Pancreat Cancer. 2018; 4(1):1-3. PMID: 30631849.
      Citations:    
    5. Sama AR, Cohen SJ. Front-Line Treatment of Metastatic Colorectal Cancer. J Oncol Pract. 2016 Dec; 12(12):1231-1233. PMID: 27943685.
      Citations:    
    6. Lin J, Patel SA, Sama AR, Hoffman-Censits JH, Kennedy B, Kilpatrick D, Ye Z, Yang H, Mu Z, Leiby B, Lewis N, Cristofanilli M, Kelly WK. A Phase I/II Study of the Investigational Drug Alisertib in Combination With Abiraterone and Prednisone for Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Abiraterone. Oncologist. 2016 Nov; 21(11):1296-1297e. PMID: 28178640.
      Citations:    
    7. Johnson JM, Chen J, Ali SM, Dardi IK, Tuluc M, Cognetti D, Campling B, Sama AR. Molecular Profiling of Synchronous Colon Cancers and Anaplastic Thyroid Cancer in a Patient with Lynch Syndrome. J Gastrointest Cancer. 2016 Oct 6. PMID: 27714650.
      Citations:    
    8. Gilani M, Intenzo CM, Bar-Ad V, Lavu H, Sama AR. Pancreatic Cancer in Lynch Syndrome: A Case Report. Case Rep Pancreat Cancer. 2016; 2(1):36-39. PMID: 30631813.
      Citations:    
    9. Lai Y, Wang C, Civan JM, Palazzo JP, Ye Z, Hyslop T, Lin J, Myers RE, Li B, Jiang B, Sama A, Xing J, Yang H. Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study. Gastroenterology. 2016 May; 150(5):1135-46. PMID: 26836586.
      Citations:    
    10. Geethakumari PR, Sama A, Caro JG, Yeo CJ, Nagalla S. "The Immune Conundrum": Acquired Hemophilia A, Immune Thrombocytopenia, and Neutropenia in a Patient with Pancreatic Cancer. Case Rep Pancreat Cancer. 2016; 2(1):14-18. PMID: 30631809.
      Citations:    
    11. Williams NL, Palmer JD, Bar-Ad V, Anné PR, Sama AR, Weinstein JC, Rufail ML, Yeo CJ, Hurwitz MD. Hepatoid Carcinoma of the Pancreas: A Case Report and Review of the Literature. Case Rep Pancreat Cancer. 2015; 1(1):3-6. PMID: 30631801.
      Citations:    
    12. Yeung V, Palmer JD, Williams N, Weinstein JC, Fortuna D, Sama A, Winter J, Bar-Ad V. Adenosquamous Carcinoma of the Pancreas in a Patient with BRCA2 Mutation: A Case Report. Case Rep Pancreat Cancer. 2015; 1(1):22-25. PMID: 30631805.
      Citations:    
    13. O'Hayer K, Farber J, Yeo CJ, Sama AR. HER-2-Positive Ampullary Adenocarcinoma: A Case Report. Case Rep Pancreat Cancer. 2015; 1(1):7-10. PMID: 30631802.
      Citations:    
    14. Kistler CA, Johnson JM, Winter JM, Baliff JP, Siddiqui AA, Sama AR. A case of periampullary adenocarcinoma in neurofibromatosis type 1. J Gastrointest Oncol. 2014 Dec; 5(6):E96-9. PMID: 25436139.
      Citations:    
    15. Sama AR, Schilder RJ. Refractory fallopian tube carcinoma - current perspectives in pathogenesis and management. Int J Womens Health. 2014; 6:149-57. PMID: 24511245.
      Citations:    
    Sama's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (17)
    Explore
    _
    Co-Authors (26)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _